Title: Reproductive toxicity testing of therapeutic biotechnology agents
Abstract: TeratologyVolume 53, Issue 3 p. 185-195 Proceedings of the Workshop “Reproductive Toxicity Testing of Biotechnology Agents” Reproductive toxicity testing of therapeutic biotechnology agents Judith W. Henck, Corresponding Author Judith W. Henck Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48105Parke-Davis Pharmaceutical Research, 2800 Plymouth Road, Ann Arbor, MI 48105Search for more papers by this authorKim G. Hilbish, Kim G. Hilbish Miles, Inc., Elkhart, Indiana 46515Search for more papers by this authorMercedes A. Serabian, Mercedes A. Serabian USFDA, Rockville, Maryland 20852Search for more papers by this authorJoy A. Cavagnaro, Joy A. Cavagnaro USFDA, Rockville, Maryland 20852Search for more papers by this authorAndrew G. Hendrickx, Andrew G. Hendrickx California Regional Primate Research Center, Davis, California 95616Search for more papers by this authorNarsingh D. Agnish, Narsingh D. Agnish Hoffman-LaRoche, Inc., Nutley, New Jersey 07110Search for more papers by this authorAda H. C. Kung, Ada H. C. Kung Skyline Technology Consulting Group, Inc., San Francisco, California 94133Search for more papers by this authorJoyce Mordenti, Joyce Mordenti Genentech, Inc., South San Francisco, California 94080Search for more papers by this author Judith W. Henck, Corresponding Author Judith W. Henck Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48105Parke-Davis Pharmaceutical Research, 2800 Plymouth Road, Ann Arbor, MI 48105Search for more papers by this authorKim G. Hilbish, Kim G. Hilbish Miles, Inc., Elkhart, Indiana 46515Search for more papers by this authorMercedes A. Serabian, Mercedes A. Serabian USFDA, Rockville, Maryland 20852Search for more papers by this authorJoy A. Cavagnaro, Joy A. Cavagnaro USFDA, Rockville, Maryland 20852Search for more papers by this authorAndrew G. Hendrickx, Andrew G. Hendrickx California Regional Primate Research Center, Davis, California 95616Search for more papers by this authorNarsingh D. Agnish, Narsingh D. Agnish Hoffman-LaRoche, Inc., Nutley, New Jersey 07110Search for more papers by this authorAda H. C. Kung, Ada H. C. Kung Skyline Technology Consulting Group, Inc., San Francisco, California 94133Search for more papers by this authorJoyce Mordenti, Joyce Mordenti Genentech, Inc., South San Francisco, California 94080Search for more papers by this author First published: March 1996 https://doi.org/10.1002/(SICI)1096-9926(199603)53:3<185::AID-TERA6>3.0.CO;2-3Citations: 42AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Literature Cited Allansmith, M., B. H. McClellan, M. Butterworth, and J. R. Maloney (1968) The development of immunoglobulin levels in man. J. Pediatr., 72: 276–290 Boscato, L. M., and M. C. Stuart (1988) Heterophilic antibodies: A problem for all immunoassays. Clin. Chem., 34: 27–33. Bryson, H. M., and E. M. Sorkin (1994) Dornase alfa: A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs, 48: 894–906. Byrn, R. A., I., Sekigawa, S. Chamow, J. S. Johnson, T. J. Gregory, D. J. Capon, and J. E. Groopman (1989) Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. J. Virol., 63: 4370–4375. Byrn, R. A., J., Mordenti, C. Lucas, D. Smith, S. A. Marsters, J. S. Johnson, P. Cossum, S. M. Chamow, F. M. Wurm, T. Gregory, J. E. Groopman, and D. J. Capon (1990) Biological properties of CD4 immunoadhesin. Nature, 344: 667–670. Capon, D., S., Chamow, J. Mordenti, S. A. Marsters, T. Gregory, H. Mitsuya, R. A. Bum, C. Lucas, F. M. Wurm, J. E. Groopman, S. Broder, and D. H. Smith (1989) Designing CD4 immunoadhesins for AIDS therapy. Nature, 337: 525–531. Cavagnaro, J. A. (1993) Preclinical safety assessment of biological products. In: Biologics Development: A Regulatory Overview. M. Matthieu, ed. Paraxel International Corp., Waltham, Massachusetts, pp. 23–40. Clarke, D. O., B. A., Elswick, F. Welsch, and R. B. Conolly (1993) Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: A physiologically based mathematical model. Toxicol. Appl. Pharmacol., 121: 239–252. Dean, J. H., J. B., Cornacoff, G. J. Rosenthal, and M. I. Luster (1989) Immune system: Evaluation of injury. In: Principles and Methods of Toxicology, Second Edition. A. W. Hayes, ed. Raven Press, New York, pp. 741–760 Green, J. D. (1994) Pharmacological-toxicological expert report on recombinant human deoxyribonuclease I (rhDNase; PulmozymeTM). Hum. Exp. Toxicol., 13: 1–41. Hendrickx, A. G., and M. C. Cukierski (1987) Reproductive and developmental toxicology in nonhuman primates. Prog. Clin. Biol. Res., 235: 73–88. Hendrickx, A. G., P. E., Binkerd, and J. M. Rowland (1983) Developmental toxicity and nonhuman primates: Interspecies comparisons. In: Issues and Reviews in Teratology. H. Kalter, ed.: Plenum Publishing Corporation, New York, Vol. 1, pp. 149–180. Hobson, W. C., and G. B. Fuller (1987) Species selection for safety evaluation of biotechnology products. Prog. Clin. Biol. Res., 235: 55–71. International Conference on Harmonisation (ICH) (1994) Guideline on detection of toxicity to reproduction for medicinal products. Fed. Reg., 59: 48746–48752. Kohn, F. R., R. J. Bauer, and A. H. C. Kung. Anti-CD5 monoclonal antibody treatment in the rat: Relationship between T-cell binding, depletion, plasma kinetics and efficacy in experimental arthritis. In preparation. Krauer, B., F., Krauer, and F. E. Hytten (1980) Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol. Ther., 10: 301–328. Kung, A. H. C., K. N., Kong, K. A. Achilles, V. L. Mohler, and M. L. White (1994) A continuous infusion animal model for the immunoconjugate, XomaZyme-CD5 Plus, in the rat. J. Am. Coll. Toxicol., 13: 64–75. Kung, A. H. C., J., Cavagnaro, A. Makin, M. A. White, and K. N. Kong (1995) Toxicologic evaluations of an immunotoxin, H65-RTA. Fundam. Appl. Toxicol., 26: 75–84. Lee, K. B., Jr., and G. S., Burrill (1994) Biotech 95: Reform, Restructure, Renewal. The Industry Annual Report. Palo Alto, California: Ernst & Young LLP, pp. 22–23. Maddon, P. J., A. G., Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell, 47: 333–348. Manson, J. M., and L. D. Wise (1991). Teratogens. In: Casarett & Doull's Toxicology. M. O. Amdur, J. Doull and C. Klaassen, eds. Pergamon Press, New York, pp. 226–254. Mordenti, J., S. A., Chen and B. L. Ferraiolo (1993) Pharmacokinetics of interferon-gamma. In: Therapeutics Proteins: Pharmacokinetics and Pharmacodynamics. A. H. C. Kung, R. A. Baughman, and J. W. Larrick, eds. W. H. Freeman and Company, New York, pp. 187–199. O'Flaherty, E. J., W., Scott, C. Schreiner, and R. Beliles (1992) A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid. Toxicol. Appl. Pharmacol., 112: 245–256. Olanoff, L., and J. Anderson (1980) Controlled release of tetracycline-III: A physiological pharmacokinetic model of the pregnant rat. J. Pharmacokinet. Biopharm., 8: 599–620. Pacifici, G. M., and R. Nottoli (1995) Placental transfer of drugs administered to the mother. Clin. Pharmacokinet. 28: 235–269. Rubin, S. (1993) Biotechnology and the pharmaceutical industry. Cancer Invest., 11: 451–457. Siegel, J. P., T., Gerrard, J. A. Cavagnaro, P. Keegan, R. P. Cohen, and K. Zoon (1995) Development of biological therapeutics for oncologic use. In: Biological Therapy of Cancer, Second Edition. V. T. De Vita, S. Hellman, and S. A. Rosenberg, eds. J. B. Lippincott Co., Philadelphia, pp. 879–890. Smith, D., R. A., Byrn, S. Marsters, T. Gregory, J. E. Groopman, and D. J. Capon (1987) Blocking of HIV-1 infectivity by soluble, secreted form of the CD4 antigen. Science, 238: 1704–1707. Stromberg, K., M. S., Chapekar, B. A. Goldman, W. A. Chambers, and J. A. Cavagnaro (1995) Regulatory concerns in the development of topical recombinant ophthalmic and cutaneous wound healing biologics. Wound Rep. Reg., 2: 155–164. Terrell, T. G., and J. D. Green (1993) Comparative pathology of recombinant murine interferon-gamma in mice and recombinant human interferon-gamma in cynomolgus monkeys. Int. Rev. Exp. Pathol., 34: 73–101. Trown, P. W., R. J., Wills, and J. J. Kamm (1986) The preclinical development of Roferon®-A. Cancer 57: 1648–1656. Ward, R. M. (1995) Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations. Clin. Pharmacokinet. 28: 343–350. Weber, T. H., K., Kapyaho, and P. Tanner (1990) Endogenous interference in immunoassays in clinical chemistry: A review. Scand. J. Clin. Lab. Invest. “Suppl.”, 50: 77–82. Citing Literature Volume53, Issue3March 1996Pages 185-195 ReferencesRelatedInformation
Publication Year: 1996
Publication Date: 1996-03-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 54
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot